Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The interaction between volatile sulfur compounds (VSCs) and salivary proteins within the oral pellicle is a fundamental process in the development of oral malodor, or halitosis. The acquired enamel pellicle (AEP) is a thin, acellular film formed by the selective adsorption of salivary proteins, such as mucins, statherin, and proline-rich proteins, onto the tooth surface (Siqueira et al., 2012, PubMed). This proteinaceous layer serves as a substrate for anaerobic oral bacteria, which utilize proteolytic enzymes to break down sulfur-containing amino acids like cysteine and methionine into VSCs, primarily hydrogen sulfide and methyl mercaptan (Scully & Greenman, 2008, Periodontology 2000). Beyond their role in odor, VSCs are known to increase the permeability of the oral mucosa and may exacerbate inflammatory responses in periodontal tissues (Yaegaki & Coil, 2000, Journal of the Canadian Dental Association). Therapeutic management typically involves the use of metal ions, particularly zinc, which neutralize VSCs through chemical precipitation and enzymatic inhibition. Additionally, antimicrobial agents are employed to disrupt the bacterial biofilm associated with the pellicle to reduce the rate of protein degradation.
Zinc ions chemically neutralize volatile sulfur compounds by reacting with them to form stable, non-volatile metal sulfides and by inhibiting the bacterial thiol-containing enzymes required for the degradation of salivary proteins (Fedorczak et al., 2012, Journal of Breath Research). Antimicrobial agents like chlorhexidine reduce the total load of anaerobic bacteria that colonize the oral pellicle and metabolize proteins into malodorous gases (Scully & Greenman, 2008, Periodontology 2000).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Volatile sulfur compounds and salivary proteins in oral pellicle.